ulfamid 20 mg filmsko obložene tablete
krka, d.d., novo mesto - famotidin - filmsko obložena tableta - famotidin 20 mg / 1 tableta - famotidin
ulfamid 20 mg filmsko obložene tablete
krka, d.d., novo mesto - famotidin - filmsko obložena tableta - famotidin 20 mg / 1 tableta - famotidin
ulfamid 40 mg filmsko obložene tablete
krka, d.d., novo mesto - famotidin - filmsko obložena tableta - famotidin 40 mg / 1 tableta - famotidin
ulfamid 40 mg filmsko obložene tablete
krka, d.d., novo mesto - famotidin - filmsko obložena tableta - famotidin 40 mg / 1 tableta - famotidin
ulfamid 20 mg filmsko obložene tablete
krka, d.d., novo mesto - famotidin - filmsko obložena tableta - famotidin 20 mg / 1 tableta - famotidin
atazanavir accord 300 mg trde kapsule
atazanavir - kapsula, trda - atazanavir 300 mg / 1 kapsula - atazanavir
abatixent 2,5 mg filmsko obložene tablete
apiksaban - filmsko obložena tableta - apiksaban 2,5 mg / 1 tableta - apiksaban
abatixent 2,5 mg filmsko obložene tablete
apiksaban - filmsko obložena tableta - apiksaban 2,5 mg / 1 tableta - apiksaban
abatixent 5 mg filmsko obložene tablete
apiksaban - filmsko obložena tableta - apiksaban 5 mg / 1 tableta - apiksaban
calquence
astrazeneca ab - acalabrutinib - levkemija, limfocitna, kronična, b-celica - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.